Physician profile
Benjamin Michael Conoyer
NPI 1184817629
$2,196.33
in general payments reported to CMS, 2019-2025
26 companies · $380 in 2025
The $380 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $395 · 2020: $59.82 · 2021: $282 · 2022: $421 · 2023: $376 · 2024: $283 · 2025: $380.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,039.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,038.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $368.95 | 2019-2025 | Dupixent |
| Optinose US, INC. | $275.39 | 2019-2025 | |
| Stryker Corporation | $265.94 | 2019-2025 | Audion Et Dilation System, Clarifix, Scopis Ent |
| Glaxosmithkline, LLC. | $180.94 | 2022-2025 | Nucala |
| Intersect Ent, INC. | $180.25 | 2019-2021 | |
| Acclarent, INC | $133.64 | 2021 | |
| Genzyme Corporation | $92.50 | 2022-2025 | |
| Ethicon US, LLC | $83.75 | 2022-2023 | Surgiflo Hemostatic Matrix, Ethicon, Vistaseal |
| Smith+Nephew, INC. | $71.38 | 2019-2023 | Rf20000 |
| Kaleo, INC. | $62.42 | 2019-2022 | |
| Genentech USA, INC. | $60.33 | 2019 | |
| Novartis Pharmaceuticals Corporation | $53.78 | 2019-2020 | |
| Karl Storz Endoscopy-America | $47.91 | 2019 | |
| Phadia US INC. | $39.64 | 2023-2024 | Immunocap |
| Davol INC. | $37.33 | 2022-2023 | Arista Ah Flexitip |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $34.80 | 2019 | |
| Neurent Medical Limited | $34.72 | 2024 | Neuromark Device, Neuromark Radiofrequency Console |
| Merck Sharp & Dohme LLC | $32.50 | 2023 | |
| Itamar Medical INC | $23.07 | 2024 | Watchpatone |
| Ars Pharmaceuticals Operations, INC. | $23.00 | 2025 | Neffy |
| Kowa Pharmaceuticals America, INC. | $19.24 | 2022 | |
| Inspire Medical Systems, INC. | $18.57 | 2024 | Inspire |
| Medtronic, INC. | $16.40 | 2024 | Propel |
| Astrazeneca Pharmaceuticals LP | $15.52 | 2025 | Tezspire |
| Arbor Pharmaceuticals, INC. | $13.44 | 2019 | |
| Misonix INC | $10.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Conoyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.